Goldman Sachs starts coverage for IDEXX Laboratories stock at USD 740.00
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
Goldman Sachs has initiated coverage of IDEXX Laboratories (ISIN US45168D1046) with a Buy rating and a price target of USD 740.00. This target is 32.87 percent above the latest Nasdaq price. IDEXX Laboratories reported strong second-quarter 2026 revenue of USD 1.22 billion, up 9.70 percent year-over-year, and is set to release its third-quarter results on November 2, 2026.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.